Neuromedin U receptor

neuromedin U receptor 2
neuromedin U receptor 2
Identifiers
Symbol	NMUR2
Alt. symbols	NMU2R
NCBI gene	56923
HGNC	16454
OMIM	605108
RefSeq	NM_020167
UniProt	Q9GZQ4
Other data
Locus	Chr. 5 q33.1
Structures
Search for
Structures	Swiss-model
Domains	InterPro

Search for
Structures	Swiss-model
Domains	InterPro

neuromedin U receptor 1
neuromedin U receptor 1
Identifiers
Symbol	NMUR1
Alt. symbols	GPR66
NCBI gene	10316
HGNC	4518
OMIM	604153
RefSeq	NM_006056
UniProt	Q9HB89
Other data
Locus	Chr. 2 q37.1
Structures
Search for
Structures	Swiss-model
Domains	InterPro

The neuromedin U receptors are two G-protein coupled receptors which bind the neuropeptide hormones neuromedin U and neuromedin S.^[1] There are two subtypes of the neuromedin U receptor, each encoded by a separate gene (NMUR1, NMUR2).

Selective Ligands[edit]

Neuromedin U is an agonist at both the NMU₁ and NMU₂ subtypes, while neuromedin S is selective for NMU₂, and is a more potent agonist at this subtype than neuromedin U.^[2]^[3] Several other peptide and non-peptide ligands are also available for the NMU receptors.

Agonists[edit]

Non-selective

Neuromedin U
non-peptide NMU modulators ^[4]^[5]

NMU₂ selective

Neuromedin S

Antagonists[edit]

NMU₂ selective

R-PSOP ^[6]

References[edit]

^ Brighton PJ, Szekeres PG, Willars GB (June 2004). "Neuromedin U and its receptors: structure, function, and physiological roles". Pharmacological Reviews. 56 (2): 231–48. doi:10.1124/pr.56.2.3. PMID 15169928. S2CID 884735.
^ Mitchell J, Maguire J, Davenport A (June 2009). "Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S". British Journal of Pharmacology. 158 (1): 87–103. doi:10.1111/j.1476-5381.2009.00252.x. PMC 2795236. PMID 19519756.
^ Peier A, Kosinski J, Cox-York K, Qian Y, Desai K, Feng Y, Trivedi P, Hastings N, Marsh DJ (July 2009). "The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2)". Endocrinology. 150 (7): 3101–9. doi:10.1210/en.2008-1772. PMC 2703546. PMID 19324999.
^ Meng T, Su HR, Binkert C, Fischli W, Zhou L, Shen JK, Wang MW (April 2008). "Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay". Acta Pharmacologica Sinica. 29 (4): 517–27. doi:10.1111/j.1745-7254.2008.00769.x. PMID 18358099.
^ Kajino M, Hinuma S, Tarui N, Yamashita T, Nakayama Y. Receptor regulators. European Patent EP 1559428 A1. Published 03.08.2005
^ Liu JJ, Payza K, Huang J, Liu R, Chen T, Coupal M, Laird JM, Cao CQ, Butterworth J, Lapointe S, Bayrakdarian M, Trivedi S, Bostwick JR (July 2009). "Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2". The Journal of Pharmacology and Experimental Therapeutics. 330 (1): 268–75. doi:10.1124/jpet.109.152967. PMID 19369576. S2CID 7366636.

External links[edit]

"Neuromedin U Receptors". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Archived from the original on 2016-03-03. Retrieved 2007-10-25.
Neuromedin+U+Receptor at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

This transmembrane receptor-related article is a stub. You can help Wikipedia by expanding it.

[pmid15169928-1] Brighton PJ, Szekeres PG, Willars GB (June 2004). "Neuromedin U and its receptors: structure, function, and physiological roles". Pharmacological Reviews. 56 (2): 231–48. doi:10.1124/pr.56.2.3. PMID 15169928. S2CID 884735.

[pmid19519756-2] Mitchell J, Maguire J, Davenport A (June 2009). "Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S". British Journal of Pharmacology. 158 (1): 87–103. doi:10.1111/j.1476-5381.2009.00252.x. PMC 2795236. PMID 19519756.

[pmid19324999-3] Peier A, Kosinski J, Cox-York K, Qian Y, Desai K, Feng Y, Trivedi P, Hastings N, Marsh DJ (July 2009). "The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2)". Endocrinology. 150 (7): 3101–9. doi:10.1210/en.2008-1772. PMC 2703546. PMID 19324999.

[pmid18358099-4] Meng T, Su HR, Binkert C, Fischli W, Zhou L, Shen JK, Wang MW (April 2008). "Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay". Acta Pharmacologica Sinica. 29 (4): 517–27. doi:10.1111/j.1745-7254.2008.00769.x. PMID 18358099.

[5] Kajino M, Hinuma S, Tarui N, Yamashita T, Nakayama Y. Receptor regulators. European Patent EP 1559428 A1. Published 03.08.2005

[pmid19369576-6] Liu JJ, Payza K, Huang J, Liu R, Chen T, Coupal M, Laird JM, Cao CQ, Butterworth J, Lapointe S, Bayrakdarian M, Trivedi S, Bostwick JR (July 2009). "Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2". The Journal of Pharmacology and Experimental Therapeutics. 330 (1): 268–75. doi:10.1124/jpet.109.152967. PMID 19369576. S2CID 7366636.

[1]

[2]

[3]

[4]

[5]

[6]

Neuromedin U receptor

Selective Ligands[edit]

Agonists[edit]

Antagonists[edit]

References[edit]

External links[edit]

Premium Membership

€4.95

Create a Premium Account quick and easy

Save your Favourite Pages

Listen to any page in Audio

Colour Night Mode